224 related articles for article (PubMed ID: 26765125)
1. A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia.
Symonds EL; Pedersen SK; Baker RT; Murray DH; Gaur S; Cole SR; Gopalsamy G; Mangira D; LaPointe LC; Young GP
Clin Transl Gastroenterol; 2016 Jan; 7(1):e137. PubMed ID: 26765125
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia.
Pedersen SK; Symonds EL; Baker RT; Murray DH; McEvoy A; Van Doorn SC; Mundt MW; Cole SR; Gopalsamy G; Mangira D; LaPointe LC; Dekker E; Young GP
BMC Cancer; 2015 Oct; 15():654. PubMed ID: 26445409
[TBL] [Abstract][Full Text] [Related]
3. Low Sensitivity of Fecal Immunochemical Tests and Blood-Based Markers of DNA Hypermethylation for Detection of Sessile Serrated Adenomas/Polyps.
Cock C; Anwar S; Byrne SE; Meng R; Pedersen S; Fraser RJL; Young GP; Symonds EL
Dig Dis Sci; 2019 Sep; 64(9):2555-2562. PubMed ID: 30835026
[TBL] [Abstract][Full Text] [Related]
4. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
[TBL] [Abstract][Full Text] [Related]
5. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
[TBL] [Abstract][Full Text] [Related]
6. A two-gene blood test for methylated DNA sensitive for colorectal cancer.
Pedersen SK; Baker RT; McEvoy A; Murray DH; Thomas M; Molloy PL; Mitchell S; Lockett T; Young GP; LaPointe LC
PLoS One; 2015; 10(4):e0125041. PubMed ID: 25928810
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancer.
Young GP; Symonds EL; Nielsen HJ; Ferm L; Christensen IJ; Dekker E; van der Vlugt M; Mallant-Hent RC; Boulter N; Yu B; Chan M; Tevz G; LaPointe LC; Pedersen SK
Clin Epigenetics; 2021 Jan; 13(1):14. PubMed ID: 33478584
[TBL] [Abstract][Full Text] [Related]
8. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.
Vasilyev S; Smirnova E; Popov D; Semenov A; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Accuracy of a Qualitative Fecal Immunochemical Test Varies With Location of Neoplasia But Not Number of Specimens.
Wong MC; Ching JY; Chan VC; Lam TY; Shum JP; Luk AK; Wong SS; Ng SC; Ng SS; Wu JC; Chan FK; Sung JJ
Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1472-9. PubMed ID: 25724708
[TBL] [Abstract][Full Text] [Related]
10. Demand for Colonoscopy in Colorectal Cancer Screening Using a Quantitative Fecal Immunochemical Test and Age/Sex-Specific Thresholds for Test Positivity.
Chen SL; Hsu CY; Yen AM; Young GP; Chiu SY; Fann JC; Lee YC; Chiu HM; Chiou ST; Chen HH
Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):704-709. PubMed ID: 29593012
[No Abstract] [Full Text] [Related]
11. Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1.
Pedersen SK; Musher BL; LaPointe LC; Tuck MK; Symonds EL; Loayza N; Young GP
Cancer; 2022 May; 128(10):1921-1928. PubMed ID: 35290664
[TBL] [Abstract][Full Text] [Related]
12. A cross-sectional study comparing a blood test for methylated BCAT1 and IKZF1 tumor-derived DNA with CEA for detection of recurrent colorectal cancer.
Young GP; Pedersen SK; Mansfield S; Murray DH; Baker RT; Rabbitt P; Byrne S; Bambacas L; Hollington P; Symonds EL
Cancer Med; 2016 Oct; 5(10):2763-2772. PubMed ID: 27726312
[TBL] [Abstract][Full Text] [Related]
13. Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia.
Kapidzic A; van der Meulen MP; Hol L; van Roon AH; Looman CW; Lansdorp-Vogelaar I; van Ballegooijen M; van Vuuren AJ; Reijerink JC; van Leerdam ME; Kuipers EJ
Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1464-71.e4. PubMed ID: 25724706
[TBL] [Abstract][Full Text] [Related]
14. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumour DNA for monitoring colorectal cancer-a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection.
Symonds EL; Pedersen SK; Murray DH; Jedi M; Byrne SE; Rabbitt P; Baker RT; Bastin D; Young GP
Clin Epigenetics; 2018; 10():63. PubMed ID: 29796114
[TBL] [Abstract][Full Text] [Related]
16. Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study.
Liles EG; Perrin N; Rosales AG; Smith DH; Feldstein AC; Mosen DM; Levin TR
BMC Cancer; 2018 May; 18(1):509. PubMed ID: 29720130
[TBL] [Abstract][Full Text] [Related]
17. Screening for colon cancer: A test for occult blood.
Khakimov N; Khasanova G; Ershova K; Gibadullina L; Vetkina T; Lobisheva G; Chumakova A
Int J Risk Saf Med; 2015; 27 Suppl 1():S110-1. PubMed ID: 26639687
[TBL] [Abstract][Full Text] [Related]
18. Detection of hypermethylated BCAT1 and IKZF1 DNA in blood and tissues of colorectal, breast and prostate cancer patients.
Winter JM; Sheehan-Hennessy L; Yao B; Pedersen SK; Wassie MM; Eaton M; Chong M; Young GP; Symonds EL
Cancer Biomark; 2022; 34(3):493-503. PubMed ID: 35253733
[TBL] [Abstract][Full Text] [Related]
19. Direct Comparison of Diagnostic Performance of 9 Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening.
Gies A; Cuk K; Schrotz-King P; Brenner H
Gastroenterology; 2018 Jan; 154(1):93-104. PubMed ID: 28958859
[TBL] [Abstract][Full Text] [Related]
20. Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use.
Rozen P; Comaneshter D; Levi Z; Hazazi R; Vilkin A; Maoz E; Birkenfeld S; Niv Y
Cancer; 2010 May; 116(9):2115-25. PubMed ID: 20186820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
